Table 3.
Multivariable logistic regression for being offered a PAMORA
| Odds ratio | 95% CI | P | |
| Intercept | 0.03 | 0.00–0.37 | 0.01 |
| Private insurance | 1.28 | 0.60–2.78 | 0.52 |
| Caucasian race | 0.82 | 0.27–2.46 | 0.72 |
| Female sex | 0.98 | 0.44–2.18 | 0.96 |
| ECI | 1.04 | 0.96–1.12 | 0.34 |
| GI provider | 12.7 | 5.42–29.7 | <0.01 |
| BMI | 1.00 | 0.95–1.06 | 0.95 |
| Age | 1.03 | 1.00–1.06 | 0.07 |
| MME | 1.00 | 1.00–1.00 | 0.05 |
| Laxatives trialed | 0.90 | 0.65–1.26 | 0.53 |
P values less than 0.05 are given in bold.
BMI, body mass index; CI, confidence interval; ECI, Elixhauser comorbidity index; GI, gastrointestinal; MME, morphine milligram equivalent; PAMORA, peripherally acting u-opioid receptor antagonists.